Double maintains 2 strategies that include AVNS - Avanos Medical, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SAVA | -0.01% | $84.54M | -85.83% | 0.00% |
CREG | -0.13% | $5.81M | -77.49% | 0.00% |
GORV | 0.31% | $25.03M | -91.07% | 0.00% |
OKLO | 0.38% | $8.08B | +552.42% | 0.00% |
EQX | -0.44% | $4.30B | +8.60% | 0.00% |
NEUE | -0.48% | $61.96M | +27.57% | 0.00% |
BPT | 0.50% | $11.00M | -79.19% | 0.00% |
STG | 0.53% | $29.06M | -28.79% | 0.00% |
PRPO | -0.61% | $16.43M | +109.40% | 0.00% |
NRDS | -0.62% | $814.42M | -25.14% | 0.00% |
PRPH | 0.65% | $15.25M | -91.22% | 0.00% |
LITB | 0.66% | $21.70M | -78.27% | 0.00% |
NNE | 0.73% | $1.43B | +47.44% | 0.00% |
QBTS | 0.88% | $4.38B | +1,129.82% | 0.00% |
PSQH | 0.90% | $93.81M | -45.36% | 0.00% |
GFI | -1.03% | $20.47B | +53.49% | 2.38% |
GRMN | -1.18% | $40.12B | +27.89% | 1.52% |
BULL | -1.18% | $5.00B | -2.63% | 0.00% |
ATOM | -1.28% | $154.13M | +31.76% | 0.00% |
LRN | 1.29% | $6.34B | +106.55% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RDDT | -10.60% | $26.39B | +123.84% | 0.00% |
DFDV | -9.45% | $247.94M | +1,821.34% | 0.00% |
HUSA | -7.02% | $22.94M | -6.82% | 0.00% |
SYPR | -5.76% | $52.86M | +19.79% | 0.00% |
XBIO | -5.59% | $5.44M | -13.27% | 0.00% |
OMCL | -5.53% | $1.38B | +8.53% | 0.00% |
SCKT | -4.28% | $9.19M | +7.41% | 0.00% |
MVO | -4.01% | $66.13M | -38.96% | 21.90% |
PULM | -3.98% | $25.57M | +262.69% | 0.00% |
CME | -3.86% | $99.01B | +39.76% | 3.87% |
BTCT | -3.56% | $18.98M | +37.85% | 0.00% |
K | -3.40% | $27.41B | +36.96% | 2.88% |
LPTH | -3.06% | $129.98M | +140.48% | 0.00% |
CCEC | -2.71% | $1.02B | +3.91% | 2.61% |
VSA | -2.54% | $8.67M | -15.70% | 0.00% |
CANG | -2.42% | $300.13M | +167.07% | 0.00% |
EXEL | -2.20% | $11.91B | +94.35% | 0.00% |
VHC | -2.15% | $45.90M | +59.26% | 0.00% |
VSTA | -1.94% | $342.46M | +40.00% | 0.00% |
RLMD | -1.92% | $20.25M | -79.67% | 0.00% |
Yahoo
Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer.
SeekingAlpha
Markets were mixed in Q1 as the new presidential administration introduced a flurry of activity, creating some uncertainty about the path forward. Read more here.
Yahoo
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Yahoo
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
Yahoo
Avanos Medical ( NYSE:AVNS ) First Quarter 2025 Results Key Financial Results Revenue: US$167.5m (flat on 1Q 2024). Net...
Yahoo
Avanos Medical Inc (AVNS) reports robust growth in Specialty Nutrition Systems but faces tariff-related headwinds impacting future earnings.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BLKB | 63.10% | $3.11B | -15.89% | 0.00% |
THRY | 60.80% | $521.80M | -33.05% | 0.00% |
GIC | 56.80% | $1.05B | -12.69% | 3.73% |
CPF | 55.43% | $749.93M | +31.13% | 3.79% |
ATNI | 54.74% | $251.22M | -27.59% | 5.90% |
HMST | 54.36% | $238.78M | +10.70% | 0.00% |
OI | 53.41% | $2.33B | +35.31% | 0.00% |
OPCH | 53.21% | $5.28B | +16.43% | 0.00% |
AVNT | 53.14% | $3.01B | -24.77% | 3.24% |
BC | 52.98% | $3.65B | -23.61% | 3.04% |
CLH | 52.60% | $12.38B | +2.17% | 0.00% |
PAG | 51.89% | $11.47B | +16.33% | 2.74% |
HNI | 51.76% | $2.31B | +10.22% | 2.67% |
LCII | 51.11% | $2.32B | -11.06% | 4.85% |
HFWA | 50.76% | $813.08M | +32.22% | 3.90% |
BBSI | 50.53% | $1.08B | +27.83% | 0.76% |
SRCE | 50.41% | $1.52B | +15.33% | 2.34% |
DAN | 50.00% | $2.50B | +41.34% | 2.34% |
ASIX | 49.99% | $647.53M | +5.37% | 2.65% |
UFPI | 49.86% | $6.03B | -10.91% | 1.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
KMLM | 0.12% | $188.31M | 0.9% |
IBTF | 0.12% | $2.02B | 0.07% |
TBLL | -0.26% | $2.13B | 0.08% |
TPMN | 0.53% | $30.81M | 0.65% |
UGA | -0.66% | $72.51M | 0.97% |
BNO | 0.69% | $103.68M | 1% |
UNG | -0.71% | $359.91M | 1.06% |
GBIL | -0.73% | $6.38B | 0.12% |
DBE | -0.76% | $52.44M | 0.77% |
USL | 1.03% | $42.26M | 0.85% |
IBDQ | 1.17% | $2.99B | 0.1% |
UUP | 1.23% | $211.55M | 0.77% |
USO | 1.24% | $1.18B | 0.6% |
SHYM | -1.32% | $350.04M | 0.35% |
USDU | -1.36% | $162.92M | 0.5% |
ULST | -1.42% | $662.59M | 0.2% |
XONE | -1.66% | $585.86M | 0.03% |
BILZ | -1.73% | $827.49M | 0.14% |
WEAT | -1.85% | $117.15M | 0.28% |
SHV | -2.39% | $20.67B | 0.15% |
Current Value
$12.081 Year Return
Current Value
$12.081 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -31.95% | $165.69M | 0.85% |
TAIL | -30.06% | $99.76M | 0.59% |
BTAL | -20.58% | $296.79M | 1.43% |
TFLO | -10.80% | $6.83B | 0.15% |
CTA | -10.36% | $1.06B | 0.76% |
IVOL | -9.54% | $349.27M | 1.02% |
FTSD | -7.67% | $231.79M | 0.25% |
CLIP | -7.31% | $1.52B | 0.07% |
KCCA | -6.16% | $105.63M | 0.87% |
BILS | -5.82% | $3.86B | 0.1356% |
FXY | -4.73% | $815.67M | 0.4% |
SGOV | -4.40% | $49.84B | 0.09% |
XHLF | -4.26% | $1.73B | 0.03% |
FXE | -4.23% | $568.58M | 0.4% |
AGZD | -4.09% | $102.66M | 0.23% |
BSMW | -3.29% | $107.26M | 0.18% |
BIL | -3.16% | $42.87B | 0.1356% |
XBIL | -2.95% | $783.57M | 0.15% |
UDN | -2.50% | $147.88M | 0.78% |
USFR | -2.47% | $18.51B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RZV | 59.28% | $203.08M | 0.35% |
XSLV | 59.04% | $281.62M | 0.25% |
SMDV | 58.16% | $653.56M | 0.4% |
VIOV | 57.72% | $1.27B | 0.1% |
DES | 57.49% | $1.85B | 0.38% |
SLYV | 57.36% | $3.65B | 0.15% |
XSHD | 57.32% | $73.44M | 0.3% |
IJS | 57.31% | $6.08B | 0.18% |
REGL | 56.60% | $1.78B | 0.4% |
BSVO | 56.49% | $1.46B | 0.47% |
RWJ | 56.14% | $1.51B | 0.39% |
IWN | 55.91% | $10.89B | 0.24% |
XSVM | 55.89% | $571.12M | 0.37% |
SMMV | 55.89% | $316.75M | 0.2% |
CALF | 55.83% | $4.17B | 0.59% |
TPSC | 55.82% | $205.22M | 0.52% |
VIOO | 55.49% | $2.86B | 0.1% |
SPSM | 55.41% | $11.28B | 0.03% |
IJR | 55.26% | $78.78B | 0.06% |
EES | 55.12% | $583.35M | 0.38% |